Less Ads, More Data, More Tools Register for FREE

Pin to quick picksODX.L Regulatory News (ODX)

  • There is currently no data for ODX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Ten year exclusive distribution agreement

24 May 2011 07:00

RNS Number : 1215H
Omega Diagnostics Group PLC
24 May 2011
 



 

Omega Diagnostics Group PLC

("Omega" or "the Company")

 

Ten year exclusive distribution agreement ("Agreement")

 

Omega, the AIM listed medical diagnostics company, announces that its subsidiary, Cambridge Nutritional Sciences Limited, (CNS) has signed a ten year exclusive distribution agreement with Toyota Tsusho America Inc., (TAI) covering the future sale and distribution of its Food Detective™ product into the US market.

 

Prior to being able to sell Food Detective™ in the US market, the product will first need to undergo a regulatory approval process with the US Food and Drug Administration ("US FDA"). Under the terms of the Agreement, TAI will fund the costs involved in obtaining relevant clinical data and information needed for an intended submission under the US FDA 510(k) clearance procedure which is expected to take 1-2 years.

 

Andrew Shepherd, CEO of Omega, said: "We're very pleased to announce this deal with TAI for distribution of Food Detective™ in the US. The product has been sold in over 50 countries and is well accepted as being a reliable test for those people suffering from the effects of food intolerance. This cost effective test has great potential in the significant US market. The US FDA regulatory approval process is likely to take time and significant resources and having a strong partner such as TAI will greatly assist this process."

 

Commenting on the distribution agreement, William Weiner, COO of TAI, said: "Toyota Tsusho America is excited to work with CNS by providing Food Detective™, which may help meet the needs of Americans who suffer from symptoms related to food intolerance. Food Detective™ provides TAI another proprietary diagnostic test to add to its increasing portfolio. Utilising our knowledge and experience in the diagnostic testing market in the US, along with our superior logistics, and supply chain, we look forward to selling the product through a variety of sales channels, after receiving FDA clearance."

 

 

Further enquiries:

 

Omega Diagnostics Group PLC

Tel: 01259 763 030

Andrew Shepherd, Chief Executive

Kieron Harbinson, Group Finance Director

www.omegadiagnostics.com

Cenkos Securities plc

Tel: 020 7397 8900

Ian Soanes

Elizabeth Bowman

Walbrook PR Limited

Tel: 020 7933 8780

Paul McManus

Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com

Helen Westaway

Mob: 07841 917 679 or helen.westaway@walbrookpr.com

 

 

Information on TAI:

 

Toyota Tsusho America, Inc. (TAI) is a wholly owned subsidiary of Toyota Tsusho Corporation, which was founded as a trading and supply-chain specialist of the Toyota Group. TAI has been operating in North America since 1961. Over the past four decades, it has evolved from a trader in a limited number of commodities and finished goods to a multi-business enterprise.

 

TAI combines international trading with an expansive range of domestically targeted functions including supply-chain services and intermediate goods processing. Our operating divisions pursue a broad mix of business opportunities related to both industrial and consumer products and services.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRUOOVRARAVUAR
Date   Source Headline
12th Nov 202010:04 amRNSResponse to media comment
12th Nov 20209:05 amRNSSecond Price Monitoring Extn
12th Nov 20209:00 amRNSPrice Monitoring Extension
11th Nov 20207:00 amRNSInvestor Presentation - Q&A update
10th Nov 20202:00 pmRNSPrice Monitoring Extension
10th Nov 202011:05 amRNSSecond Price Monitoring Extn
10th Nov 202011:01 amRNSPrice Monitoring Extension
9th Nov 20202:05 pmRNSSecond Price Monitoring Extn
9th Nov 20202:00 pmRNSPrice Monitoring Extension
9th Nov 202010:45 amRNSExercise of Options and Total Voting Rights
6th Nov 20209:00 amRNSExercise of Options and Total Voting Rights
3rd Nov 20207:00 amRNSChinese approval for Food Detective® test
30th Oct 20203:00 pmRNSExercise of Options and Total Voting Rights
29th Oct 20206:07 pmRNSHolding(s) in Company
28th Oct 20207:00 amRNSTrading update and notice of interim results
20th Oct 202011:00 amRNSExercise of Options and Total Voting Rights
20th Oct 20207:00 amRNSNotice of Trading Update and Investor Presentation
19th Oct 20207:00 amRNSUK-RTC contract for the Supply of Goods
14th Oct 20207:45 amRNSExercise of Options and Total Voting Rights
9th Oct 20204:15 pmRNSExercise of Options and Total Voting Rights
7th Oct 20207:00 amRNSUK Government contract for UK-RTC
6th Oct 20205:45 pmRNSHolding(s) in Company
6th Oct 20204:46 pmRNSUK Government contract for UK-RTC
6th Oct 20204:41 pmRNSSecond Price Monitoring Extn
6th Oct 20204:35 pmRNSPrice Monitoring Extension
2nd Oct 202012:00 pmRNSPreliminary report published by Ulster University
2nd Oct 202011:05 amRNSSecond Price Monitoring Extn
2nd Oct 202011:00 amRNSPrice Monitoring Extension
2nd Oct 20209:05 amRNSSecond Price Monitoring Extn
2nd Oct 20209:00 amRNSPrice Monitoring Extension
29th Sep 20207:00 amRNSInvestor Presentation
24th Sep 20202:05 pmRNSSecond Price Monitoring Extn
24th Sep 20202:00 pmRNSPrice Monitoring Extension
15th Sep 20205:51 pmRNSExercise of Options and Total Voting Rights
15th Sep 20209:45 amRNSHolding(s) in Company
14th Sep 20204:41 pmRNSSecond Price Monitoring Extn
14th Sep 20204:36 pmRNSPrice Monitoring Extension
14th Sep 20202:05 pmRNSSecond Price Monitoring Extn
14th Sep 20202:01 pmRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSExercise of Options and Total Voting Rights
10th Sep 202010:11 amRNSHolding(s) in Company
7th Sep 20202:33 pmRNSStmnt re Share Price Movement
7th Sep 20207:00 amRNSCompletion of AbC-19 self-test usability study
3rd Sep 20207:00 amRNSCE-Mark for Mologic COVID-19 antibody test
1st Sep 20204:07 pmRNSExercise of Options and Total Voting Rights
28th Aug 20209:45 amRNSHolding(s) in Company
26th Aug 202011:20 amRNSResult of AGM
26th Aug 20207:00 amRNSExercise of Options and Total Voting Rights
24th Aug 20209:30 amRNSExercise of Options and Total Voting Rights
21st Aug 20207:00 amRNSWHO Prequalification received

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.